About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
HISTORICAL VOLUME
Historical
Volume
Tatva Chintan Pharma Chem Ltd.
BSE Code
543321
ISIN Demat
INE0GK401011
Book Value
310.55
NSE Code
TATVA
Dividend Yield %
0.09
Market Cap
25822.49
P/E
653.40
EPS
1.69
Face Value
10
Exchange :
BSE
NSE
Period From :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2025
2024
Period To :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2025
2024
Date
Open Price(Rs.)
High Price(Rs.)
Low Price(Rs.)
Close Price(Rs.)
Volume
Turnover
17-Sep-2025
1124.70
1142.95
1099.85
1103.90
14070
15757070
16-Sep-2025
1065.00
1148.95
1061.90
1102.85
17103
19183041
15-Sep-2025
1011.20
1065.00
1010.05
1057.10
12856
13415841
12-Sep-2025
1009.65
1027.60
1007.30
1017.95
1070
1088549
11-Sep-2025
1025.00
1025.00
1005.85
1007.90
1563
1582375
10-Sep-2025
1025.20
1029.00
1005.00
1007.50
1292
1311924
09-Sep-2025
982.55
1031.00
982.55
1019.30
6317
6396924
08-Sep-2025
1000.05
1009.60
977.85
982.50
5523
5480628
05-Sep-2025
1024.05
1035.45
992.10
996.90
9211
9279098
04-Sep-2025
1065.00
1067.90
1033.70
1037.80
4661
4880001
03-Sep-2025
1050.55
1086.30
1046.60
1071.20
3552
3808529
02-Sep-2025
1042.05
1074.50
1037.70
1050.50
8951
9445042
01-Sep-2025
1068.45
1068.45
1021.10
1051.20
3575
3708398
Page
1
of
1
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.